Introduction: Oral isotretinoin is the only effective treatment for severe acne without an alternative. Isotretinoin has been linked to the occurrence of acute psychiatric disorders outside suicidal behaviors. There are few large-scale epidemiological studies in this area, and the putative associations are unclear. Our objective was to determine whether adolescents and young adults have an elevated risk of acute-onset psychiatric disorder requiring hospital treatment within 2 months of starting isotretinoin treatment. Methods: Our data source was the French national health insurance database (Système National des Données de Santé, SNDS), 2010–2015. We performed a case-time-control study nested in an exhaustive, nationwide cohort of all French adolescents and young adults aged 10–25 years treated with isotretinoin. The outcome was an acute-onset psychiatric disorder requiring hospitalization (including anxiety, depressive, mood, adjustment, and psychotic disorders). A conditional logistic model was used to estimate odds ratios (ORs) with their 95% confidence interval (CI) for acute psychiatric events. Results: 2,284 acute-onset psychiatric disorder requiring hospitalization were recorded for the study population of 262,786 patients. Among the patients with at least one psychiatric event, 88 had started taking isotretinoin in the risk period (0–2 months before the date of the event), versus 81 in the reference period (2–4 months before the event). A comparison with the 383 and 355 time-trend matched controls who started taking isotretinoin in the risk and reference periods, respectively, yielded a case-time-control OR (95% CI) of 1.01 (0.72–1.41). Conclusion: Psychiatric events managed outside the hospital system were not recorded. Our findings are reassuring for clinicians concerning the risk of severe acute-onset psychiatric events after isotretinoin initiation.

1.
White
GM
.
Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris
.
J Am Acad Dermatol
.
1998
;
39
(
2 Pt 3
):
S34
7
.
2.
Goulden
V
,
Stables
GI
,
Cunliffe
WJ
.
Prevalence of facial acne in adults
.
J Am Acad Dermatol
.
1999
;
41
(
4
):
577
80
.
3.
Eichenfield
DZ
,
Sprague
J
,
Eichenfield
LF
.
Management of acne vulgaris: a review
.
JAMA
.
2021
;
326
(
20
):
2055
67
.
4.
Dawson
AL
,
Dellavalle
RP
.
Acne vulgaris
.
BMJ
.
2013
;
346
:
f2634
.
5.
Williams
HC
,
Dellavalle
RP
,
Garner
S
.
Acne vulgaris
.
Lancet
.
2012
;
379
(
9813
):
361
72
.
6.
Halvorsen
JA
,
Stern
RS
,
Dalgard
F
,
Thoresen
M
,
Bjertness
E
,
Lien
L
.
Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study
.
J Invest Dermatol
.
2011
;
131
(
2
):
363
70
.
7.
Gupta
MA
,
Gupta
AK
.
Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis
.
Br J Dermatol
.
1998
;
139
(
5
):
846
50
.
8.
Purvis
D
,
Robinson
E
,
Merry
S
,
Watson
P
.
Acne, anxiety, depression and suicide in teenagers: a cross-sectional survey of New Zealand secondary school students
.
J Paediatr Child Health
.
2006
;
42
(
12
):
793
6
.
9.
Rehn
LM
,
Meririnne
E
,
Höök-Nikanne
J
,
Isometsä
E
,
Henriksson
M
.
Depressive symptoms and suicidal ideation during isotretinoin treatment: a 12-week follow-up study of male Finnish military conscripts
.
J Eur Acad Dermatol Venereol
.
2009
;
23
(
11
):
1294
7
.
10.
Ramrakha
S
,
Fergusson
DM
,
Horwood
LJ
,
Dalgard
F
,
Ambler
A
,
Kokaua
J
, et al
.
Cumulative mental health consequences of acne: 23-year follow-up in a general population birth cohort study
.
Br J Dermatol
.
2016
;
175
(
5
):
1079
81
.
11.
Picardi
A
,
Mazzotti
E
,
Pasquini
P
.
Prevalence and correlates of suicidal ideation among patients with skin disease
.
J Am Acad Dermatol
.
2006
;
54
(
3
):
420
6
.
12.
Rubinow
DR
,
Peck
GL
,
Squillace
KM
,
Gantt
GG
.
Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin
.
J Am Acad Dermatol
.
1987
;
17
(
1
):
25
32
.
13.
Newton
JN
,
Mallon
E
,
Klassen
A
,
Ryan
TJ
,
Finlay
AY
.
The effectiveness of acne treatment: an assessment by patients of the outcome of therapy
.
Br J Dermatol
.
1997
;
137
(
4
):
563
7
.
14.
Kellett
SC
,
Gawkrodger
DJ
.
The psychological and emotional impact of acne and the effect of treatment with isotretinoin
.
Br J Dermatol
.
1999
;
140
(
2
):
273
82
.
15.
Chia
CY
,
Lane
W
,
Chibnall
J
,
Allen
A
,
Siegfried
E
.
Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study
.
Arch Dermatol
.
2005
;
141
(
5
):
557
60
.
16.
Kaymak
Y
,
Taner
E
,
Taner
Y
.
Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents
.
Int J Dermatol
.
2009
;
48
(
1
):
41
6
.
17.
Ferahbas
A
,
Turan
MT
,
Esel
E
,
Utas
S
,
Kutlugun
C
,
Kilic
CG
.
A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin
.
J Dermatolog Treat
.
2004
;
15
(
3
):
153
7
.
18.
Hahm
BJ
,
Min
SU
,
Yoon
MY
,
Shin
YW
,
Kim
JS
,
Jung
JY
, et al
.
Changes of psychiatric parameters and their relationships by oral isotretinoin in acne patients
.
J Dermatol
.
2009
;
36
(
5
):
255
61
.
19.
Nevoralová
Z
,
Dvořáková
D
.
Mood changes, depression and suicide risk during isotretinoin treatment: a prospective study
.
Int J Dermatol
.
2013
;
52
(
2
):
163
8
.
20.
Huang
YC
,
Cheng
YC
.
Isotretinoin treatment for acne and risk of depression: a systematic review and meta-analysis
.
J Am Acad Dermatol
.
2017
;
76
(
6
):
1068
76.e9
.
21.
Peck
GL
,
Olsen
TG
,
Butkus
D
,
Pandya
M
,
Arnaud-Battandier
J
,
Gross
EG
, et al
.
Isotretinoin versus placebo in the treatment of cystic acne. A randomized double-blind study
.
J Am Acad Dermatol
.
1982
;
6
(
4 Pt 2 Suppl
):
735
45
.
22.
Strauss
JS
,
Rapini
RP
,
Shalita
AR
,
Konecky
E
,
Pochi
PE
,
Comite
H
, et al
.
Isotretinoin therapy for acne: results of a multicenter dose-response study
.
J Am Acad Dermatol
.
1984
;
10
(
3
):
490
6
.
23.
Le Cleach
L
,
Lebrun-Vignes
B
,
Bachelot
A
,
Beer
F
,
Berger
P
,
Brugère
S
, et al
.
Guidelines for the management of acne: recommendations from a French multidisciplinary group
.
Br J Dermatol
.
2017
;
177
(
4
):
908
13
.
24.
Sundström
A
,
Alfredsson
L
,
Sjölin-Forsberg
G
,
Gerdén
B
,
Bergman
U
,
Jokinen
J
.
Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study
.
BMJ
.
2010
;
341
:
c5812
.
25.
Droitcourt
C
,
Nowak
E
,
Rault
C
,
Happe
A
,
Le Nautout
B
,
Kerbrat
S
, et al
.
Risk of suicide attempt associated with isotretinoin: a nationwide cohort and nested case-time-control study
.
Int J Epidemiol
.
2019
;
48
(
5
):
1623
35
.
26.
Ugonabo
N
,
Love
E
,
Wong
PW
,
Rieder
EA
,
Orlow
SJ
,
Kim
RH
, et al
.
Psychiatric disorders and suicidal behavior in patients with acne prescribed oral antibiotics versus isotretinoin: analysis of a large commercial insurance claims database
.
J Am Acad Dermatol
.
2021
;
85
(
4
):
878
84
.
27.
Paljarvi
T
,
McPherson
T
,
Luciano
S
,
Herttua
K
,
Fazel
S
.
Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data
.
Br J Dermatol
.
2022
;
187
(
1
):
64
72
.
28.
Wysowski
DK
,
Pitts
M
,
Beitz
J
.
An analysis of reports of depression and suicide in patients treated with isotretinoin
.
J Am Acad Dermatol
.
2001
;
45
(
4
):
515
9
.
29.
Bremner
JD
,
Shearer
KD
,
McCaffery
PJ
.
Retinoic acid and affective disorders: the evidence for an association
.
J Clin Psychiatry
.
2012
;
73
(
1
):
37
50
.
30.
Tuppin
P
,
Rudant
J
,
Constantinou
P
,
Gastaldi-Ménager
C
,
Rachas
A
,
de Roquefeuil
L
, et al
.
Value of a national administrative database to guide public decisions: From the système national d'information interrégimes de l’Assurance Maladie (SNIIRAM) to the Système National des Données de Santé (SNDS) in France
.
Rev Epidemiol Sante Publique
.
2017
;
65
(
Suppl 4
):
S149
67
.
31.
Suissa
S
.
The case-time-control design
.
Epidemiology
.
1995
;
6
(
3
):
248
53
.
32.
Langan
SM
,
Schmidt
SA
,
Wing
K
,
Ehrenstein
V
,
Nicholls
SG
,
Filion
KB
, et al
.
The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)
.
BMJ
.
2018
;
363
:
k3532
.
33.
Crandall
J
,
Sakai
Y
,
Zhang
J
,
Koul
O
,
Mineur
Y
,
Crusio
WE
, et al
.
13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice
.
Proc Natl Acad Sci U S A
.
2004
;
101
(
14
):
5111
6
.
34.
O'Reilly
KC
,
Shumake
J
,
Gonzalez-Lima
F
,
Lane
MA
,
Bailey
SJ
.
Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice
.
Neuropsychopharmacology
.
2006
;
31
(
9
):
1919
27
.
35.
Hu
P
,
Van Dam
AM
,
Wang
Y
,
Lucassen
PJ
,
Zhou
JN
.
Retinoic acid and depressive disorders: evidence and possible neurobiological mechanisms
.
Neurosci Biobehav Rev
.
2020
;
112
:
376
91
.
36.
Maclure
M
,
Mittleman
MA
.
Should we use a case-crossover design
.
Annu Rev Public Health
.
2000
;
21
:
193
221
.
37.
Azoulay
L
,
Blais
L
,
Koren
G
,
LeLorier
J
,
Bérard
A
.
Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study
.
J Clin Psychiatry
.
2008
;
69
(
4
):
526
32
.
38.
Hallas
J
,
Pottegård
A
.
Use of self-controlled designs in pharmacoepidemiology
.
J Intern Med
.
2014
;
275
(
6
):
581
9
.
39.
Schneeweiss
S
,
Stürmer
T
,
Maclure
M
.
Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research
.
Pharmacoepidemiol Drug Saf
.
1997
;
6
(
Suppl 3
):
S51
9
.
40.
Maclure
M
,
Fireman
B
,
Nelson
JC
,
Hua
W
,
Shoaibi
A
,
Paredes
A
, et al
.
When should case-only designs be used for safety monitoring of medical products
.
Pharmacoepidemiol Drug Saf
.
2012
;
21
(
Suppl 1
):
50
61
.
41.
Hersom
K
,
Neary
MP
,
Levaux
HP
,
Klaskala
W
,
Strauss
JS
.
Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis
.
J Am Acad Dermatol
.
2003
;
49
(
3
):
424
32
.
42.
Malhi
GS
,
Mann
J
.
Depression
.
Lancet
.
2018
;
392
(
10161
):
2299
312
.
43.
Chen
YH
,
Wang
WM
,
Chung
CH
,
Tsao
CH
,
Chien
WC
,
Hung
CT
.
Risk of psychiatric disorders in patients taking isotretinoin: a nationwide, population-based, cohort study in Taiwan
.
J Affect Disord
.
2022
;
296
:
277
82
.
44.
Kridin
K
,
Ludwig
RJ
.
Isotretinoin and the risk of psychiatric disturbances: a global study shedding new light on a debatable story
.
J Am Acad Dermatol
.
2023
;
88
(
2
):
388
94
.
45.
Mostofsky
E
,
Coull
BA
,
Mittleman
MA
.
Analysis of observational self-matched data to examine acute triggers of outcome events with abrupt onset
.
Epidemiology
.
2018
;
29
(
6
):
804
16
.
You do not currently have access to this content.